Ubs Group Ag Green Light Biosciences Holdings, Pbc Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
SELL
$0.18 - $0.48 $5,760 - $15,360
-32,000 Reduced 83.38%
6,379 $1,000
Q1 2023

May 12, 2023
BUY
$0.34 - $1.19 $9,593 - $33,577
28,216 Added 277.63%
38,379 $16,000
Q4 2022

Feb 08, 2023
BUY
$1.03 - $2.0 $7,583 - $14,726
7,363 Added 262.96%
10,163 $11,000
Q3 2022

Nov 10, 2022
BUY
$0.42 - $3.92 $163 - $1,524
389 Added 16.13%
2,800 $7,000
Q2 2022

Aug 10, 2022
BUY
N/A
2,411 New
2,411 $5,000

Others Institutions Holding GRNA

# of Institutions
1
Shares Held
51.5K
Call Options Held
0
Put Options Held
0
View Full List

About GreenLight Biosciences Holdings, PBC

GRNA Quotes by TradingView
  • Ticker GRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 151,460,000
  • Description
  • GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in...
More about GRNA
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email